Rapid Relief

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with conditions such as simple backache, arthritis, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and older should carefully remove the backing from the patch and apply the sticky side to the affected area. The patch should not be left on the skin for more than a total of 8 hours per day. Application may be repeated as necessary, but should not exceed 3 times daily. After each use, the patch must be discarded.

For children under 12 years of age, the product is not recommended, and consultation with a physician is advised. It is important to supervise children when they are using this product to ensure safe and appropriate application.

Contraindications

Use of this product is contraindicated in the following situations:

Application on wounds, cuts, damaged, or infected skin is prohibited due to the risk of exacerbating the condition and causing further irritation. The product should not be applied to the eyes, mouth, genitals, or any mucous membranes, as this may lead to significant irritation or injury.

Tight bandaging or the simultaneous use of heating pads, including electric heating pads, is contraindicated due to the potential for excessive skin irritation or burns. Additionally, concurrent use with other topical analgesics is not recommended, as this may increase the risk of adverse effects.

Warnings and Precautions

For external use only. This product should be utilized strictly as directed to minimize the risk of adverse effects.

Rare cases of serious burns have been reported with similar products; therefore, caution is advised. It is imperative to avoid tight bandaging or the simultaneous use of heating pads, including electric heating pads, as these practices may lead to excessive skin irritation or burns.

Healthcare professionals should instruct patients to avoid contact with the eyes and mucous membranes. The product must not be applied to wounds or damaged skin, and concurrent use with other topical analgesics is contraindicated.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients should be advised to discontinue use and consult a healthcare provider if any of the following occur: worsening of the condition, presence of redness, development of irritation, persistence of symptoms beyond 7 days, recurrence of symptoms after resolution, or any signs of skin injury, such as pain, swelling, or blistering at the application site, as these may indicate serious burns.

Side Effects

Patients should be aware that the product is intended for external use only. In the event of worsening conditions, the presence of redness, development of irritation, or persistence of symptoms beyond 7 days, it is advised to discontinue use and consult a healthcare professional. Additionally, if symptoms resolve and then recur within a few days, medical advice should be sought.

Serious adverse reactions, although rare, may include signs of skin injury such as pain, swelling, or blistering at the site of application. These reactions can indicate the occurrence of serious burns, necessitating immediate medical attention.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Rapid Relief (cold relief patch 5% menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should not use this product without consulting a physician. It is essential for caregivers to supervise children during the use of this product to ensure safety and proper administration.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered, as the effects on fetal outcomes and breastfeeding infants are not fully established. It is essential for women of childbearing potential to discuss their individual circumstances with a healthcare provider to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Dosage adjustments may be necessary for patients with reduced renal function. It is important to monitor renal function tests regularly in patients with known kidney problems. Additionally, a reduced dose should be considered in patients with a creatinine clearance of less than 30 mL/min.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential risks associated with excessive administration of the medication.

Should an overdosage occur, it is recommended that healthcare providers assess the patient's clinical status and initiate appropriate monitoring. Symptoms of overdosage may vary depending on the medication involved and the individual patient's response.

Management procedures should include supportive care, which may involve symptomatic treatment and monitoring of vital signs. In cases where the specific antidote or treatment protocol is known, it should be administered as per established guidelines.

Healthcare professionals are encouraged to consult relevant toxicology resources or poison control centers for guidance on managing suspected overdosage cases effectively.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Serious burns have been reported in rare cases associated with the use of products of this type. While these events are infrequent, they are considered significant and warrant attention in the context of postmarketing surveillance.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to instruct patients not to use the product on wounds, cuts, damaged, or infected skin, and to avoid application on the eyes, mouth, genitals, or any mucous membranes. In the event of contact with these areas, patients should rinse thoroughly with water.

Patients should be reminded to use the product only as directed. They should be made aware that rare cases of serious burns have been reported with similar products. It is crucial to inform patients not to bandage the area tightly or use the product in conjunction with heating pads, such as electric heating pads, as this may lead to excessive skin irritation or burns.

Healthcare providers should emphasize the importance of avoiding contact with eyes and mucous membranes, and reiterate that the product should not be applied to wounds or damaged skin. Patients should also be cautioned against using the product simultaneously with other topical analgesics.

Patients should be instructed to stop using the product and consult a doctor if their condition worsens, if redness or irritation develops, or if symptoms persist for more than 7 days or clear up and recur within a few days. Additionally, they should seek medical advice if they experience signs of skin injury, such as pain, swelling, or blistering at the application site, as rare but serious burns can occur.

Storage and Handling

The product is supplied in a configuration that ensures optimal handling and storage. It should be stored at a temperature range of 15-30℃ (59-86℉) to maintain its efficacy. It is imperative to keep the product out of reach of children to prevent accidental ingestion or misuse. Proper adherence to these storage conditions is essential for preserving the integrity of the product.

Additional Clinical Information

The product is administered topically, with a recommended usage for adults and children aged 12 years and older not to exceed a total of 8 hours on the skin per day. Applications may be repeated as necessary, but should not occur more than three times daily.

Clinicians should counsel patients to consult a health professional if they are pregnant or breastfeeding before use. It is also important to advise patients to keep the product out of reach of children and to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Drug Information (PDF)

This file contains official product information for Rapid Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)